Qiagen NV | QIA - Assets

Stock Price
41.18
Daily Change
0.06 0.15%
Monthly
-11.31%
Yearly
8.84%
Q1 Forecast
40.37

Qiagen NV reported $6.3B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Akebia Therapeutics USD 364.15M 18.56M Sep/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
argenx SE USD 7.18B 973.07M Jun/2025
Avita Medical AUD 58.13M 21.58M Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Qiagen NV USD 6.3B 257.54M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Viatris USD 37.92B 491.1M Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025